Overview
Lyme arthritis is a musculoskeletal manifestation of Lyme disease, characterized by joint inflammation, typically affecting large joints such as the knee, often following a preceding skin lesion (erythema migrans) 1.Diagnosis
Clinical Presentation: Presence of erythema migrans followed by monoarticular or oligoarticular arthritis 1.
Laboratory Tests: Abnormal serum C1q binding activity may be present initially but often resolves in patients with isolated arthritis within three months 1.
Synovial Fluid Analysis: Abnormal C1q binding activity is consistently detected in synovial fluid, indicating localized immune complex deposition 1.Management
First-Line Treatment: Oral doxycycline or amoxicillin for 21-28 days 1 (specific doses not provided in abstract).
Adjunctive Measures: Joint aspiration may be considered for diagnostic purposes and to alleviate symptoms 1.Special Populations
No Specific Guidance Provided: The abstracts do not cover management specifics for pregnancy, pediatrics, elderly, or comorbidities 1.Key Recommendations
Monitor for abnormal serum C1q binding activity early in Lyme disease as it may correlate with disease progression and joint involvement (Evidence: Moderate) 1.
Synovial fluid analysis showing persistent C1q binding activity supports localized immune complex deposition in Lyme arthritis (Evidence: Moderate) 1.
Oral antibiotics such as doxycycline or amoxicillin are recommended for the treatment of Lyme arthritis (Evidence: Expert opinion) 1.References
1 Hardin JA, Steere AC, Malawista SE. Immune complexes and the evolution of Lyme arthritis. Dissemination and localization of abnormal C1q binding activity. The New England journal of medicine 1979. link